Encouraging entrepreneurs, supporting breakthrough medical and health-related technologies, and partnering with global leaders clearly supports our mission “to improve the human condition.”
Large, emerging economies are closing the gap with developed markets on health care spending as a percentage of GDP²
Israel’s proclivity for innovation, its world-class institutions and highly educated workforce have contributed to the country’s rise as a high-tech powerhouse.
Ranked first in medical device patents and second in medical device solutions per capita, Israel has been a source of breakthrough treatments and drugs such as cardiac catheters, Copaxone, PillCam, EarlySense, ReWalk, BabySense, and dozens more. Israel’s exports of life science-related products and services are valued at billions of dollars annually.³
There are approximately 1,400 life science companies operating in Israel,³ in sectors from imaging to drug delivery, to medical and surgical equipment. Nearly 25% of the Office of the Chief Scientist budget was allocated to companies involved in life sciences.4
¹WIPRO report, “Emerging Trends in the Medical Device Industry.”
²World Health Organization, Global Health Expenditure database, 2016.
³”An Introduction to Enlightened Direct Foreign Investment in Israel,” by the Foreign Investment and Industrial Cooperation Authority, Invest in Israel, Israel’s Ministry of Economy and Industry.
4IVC, Israel Advanced Technology Industry (IATI), SNC databases and IATI data analysis.
Are you a passionate entrepreneur with an idea for an exciting new medical product or technology? Contact VP New Ventures Yuval Almougy.
Interested in investment opportunities? Contact VP Business Development Barak Singer.